Clinical

Clinical

USCAP 2023: Ibex AI helps improve HER2 scoring and breast cancer diagnosis for a better identification of patients eligible for HER2-directed therapy

Clinical

USCAP 2023: The first AI solution that helps pathologists detect gastric cancer, H.pylori and clinically important features

Clinical

Institut Curie study published in a Nature Journal reporting excellent outcomes of Ibex’s AI solution for breast cancer detection

Clinical

Galen Breast helped improve diagnostic quality and supported pathologists with an efficient workflow in primary diagnosis of breast biopsies

Clinical

SABCS 2022: Ibex AI detects different HER2 and HER2 low patterns and helps scoring faint and moderate incomplete cells

Clinical

Dr. Giuseppe Mallel presents the winning case report at SIAPeC, the Italian Pathology Congress, on how AI helped detect invasive breast carcinoma in a challenging case.  

Clinical

Dr. Eva Comperat presenting a study of Ibex AI in Primary Diagnosis of Prostate Cancer

Clinical

Mahul Amin, MD: Ibex AI performance in prostate cancer detection

Clinical

USCAP 2022: The first-ever validation and deployment of AI-solution for gastric cancer detection 

Clinical

Dr. Anne Vincent-Salomon presenting a study of Ibex AI for Breast Cancer Diagnosis

Clinical

THE LANCET Commentary: Clinical deployment of AI for prostate cancer diagnosis

Clinical

Liron Pantanowitz, MD: Validation study at UPMC for multi-feature AI-algorithm for prostate cancer detection